Andrés Morales la Madrid
Investigador colaborador
Research group
Medicine Degree (2002) by the Universidad Peruana Cayetano Heredia (Peru). Specialty in Pediatrics (2007) from Vall Hebron Hospital (Spain). Sub Specialty in Oncology, Hematology and Stem Cell Transplantation in Pediatrics (2012) from the University of Chicago (USA). Sub Specialty in Pediatric Neuro Oncology (2013) from Harvard University (2013). Master in Hospital Management and Health Resources (2018) from the University of Barcelona (Spain).
In 2018, he was appointed Clinical Director of the Oncology Area of the SJD Barcelona Children Hospital, Spain.
He leads a clinical research project in immunotherapy for the diffuse intrinsic pontine glioma (DIPG).
Professional network profiles
Related websites
SJD Barcelona Children Hospital Last Publications
- Chavaz L, Bagchi A, Dhanda SK, Toutain F, Pfister SM, Sturm D, Pietsch T, Gielen GH, Waha A, Clarke M, Lu C, Karremann M, Benesch M, Perwein T, Nussbaumer G, Kramm C, Massimino M, Biassoni V, Vinci M, Mastronuzzi A, van Vuurden D, Veldhuijzen van Zanten SEM, Mackay A, Jones C, Jones DTW, Guerreiro Stucklin AS, Tabori U, Hawkins C, Ryall S, Morales-La Madrid A, Lassaletta A, Bailey S, Hargrave D, Chiang J, El-Ayadi M, Mançano BM, Manuel Reis R, Hagel C, Gorsi H, Silvestrini N, Gilani A, Papusha L, Klimo P Jr, Zhou X, Gajjar A, Robinson GW and von Bueren AO A systematic study of molecular diagnosis, treatment, and prognosis in infant-type hemispheric glioma: An individual patient data meta-analysis of 164 patients NEURO-ONCOLOGY . : .
- Karremann M, Gerdes T, Gielen GH, Kwiecien R, Perwein T, Hoffmann M, Azizi AA, Babor F, Barrios-Bussmann C, Behrens L, Benesch M, Bertero L, Biassoni V, Bison B, Buttarelli FR, Calaminus G, Claviez A, Distelmaier F, Ebinger M, Elayadi M, Ernst J, Eyrich M, Fleischhack G, Friedrich C, Friker LL, Garre ML, Gerber NU, Gojo J, Hargrave D, Häuser S, Hernaiz-Driever P, Holm S, Jakob M, Knirsch S, Kratz C, Krischer JM, Kühnöl C, Kumirova E, Massimino M, Vinci M, Meijer L, Metzler M, Milanaccio C, Morales-La Madrid A, Morana G, Nussbaumer G, Piccolo G, Pollo B, Reifenberger G, Reimann C, Rosenbaum T, Schiavello E, Sterba J, Sturm D, Szychot E, Valentini C, Vallero SG, Velleuer-Carlberg E, van Buiren M, Mastronuzzi A, van Vuurden D, von Bueren AO, Wiese M, Zinke C, Zlocha J, Pietsch T and Kramm CM Pediatric high-grade gliomas in patients with neurofibromatosis type 1-A collaborative cohort study from the SIOPE HGG/DIPG working group. Neuro-Oncology Practice . 13(1): 71-85.
- Nafria-Escalera B, Claverol J, Cubells M, Llanos C, Solé L, Sans E, López S, Català-Mora J, Rives-Solà S, Morales-La Madrid A, Pineda M, Garcia-Cazorla A, Nascimento-Osorio A, Morales-Ballús M, Roe D, Fortuny-Guasch C and Phillips B Cross-border access to clinical trials: participation of pediatric patients and language inclusion PEDIATRIC RESEARCH . : .
Projects
- Project name:
- LATE-AYA: Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach
- Leader
- Andrés Morales La Madrid
- Funding entities:
- European Commission
- Code
- 101214326
- Starting - finishing date:
- 2025 - 2030
- Project name:
- ADVANCED THERAPIES (RICORS-TERAV)
- Leader
- Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- RD24/0014/0006
- Starting - finishing date:
- 2025 - 2027
- Project name:
- ICF (Exploratory study on the provision of care for Adolescent and Young Adult (AYA) cancer patients in the Union)
- Leader
- Andrés Morales La Madrid
- Funding entities:
- European Commission
- Code
- 330301961
- Starting - finishing date:
- 2025 - 2026
News
-
The Institut de Recerca Sant Joan de Déu drives the first in-person meeting of the cancer Survivorship Network of Expertise of the JANE2 project
On May 9th, the Institut de Recerca Sant Joan de Déu (IRSJD) brought together the leaders of the Survivorship Network of Expertise, a network framed within the Joint Action on Network of Expertise (JANE2) project, one of the pillars of the European Beating Cancer Plan. During the meeting, key challenges and activities to advance care for cancer survivors in Europe were addressed, and a "working definition" was proposed to help establish an integrative care model for survivors.
